Dynamics of Reactive Oxygen Metabolites and Biological Antioxidant Potential in the Acute Stage of Kawasaki Disease
スポンサーリンク
概要
- 論文の詳細を見る
Background: The dynamics of oxidation/reduction control system activities using reactive oxygen metabolites (ROM) and biological antioxidant potential (BAP) in acute stage patients was evaulated to understand the mechanism of vascular injury and remodeling in Kawasaki disease (KD). Methods and Results: ROM, BAP, high-sensitivity C-reactive protein (hs-CRP), interleukin-1,2,6, and tumour necrosis factor-α in 19 KD patients were measured. ROM decreased in good correlation only with hs-CRP (P<0.05) at 2 weeks after intravenous immunoglobulin (IVIG). Patients were further classified as responding well (Group A) or responding poorly (Group B) to IVIG. Both treatment groups had significantly higher ROM values than the control group (P<0.01). ROM decreased in Group A both immediately and 2 weeks after the IVIG treatment (P<0.05), but it did not decrease in Group B until 2 weeks post-treatment (P<0.01). BAP levels were unremarkable in Group A, but were significantly lower in Group B than in both other groups (P<0.05). BAP increased in Group A 2 weeks after IVIG treatment (P<0.01), but remained low in Group B (P<0.01). Conclusions: Acute stage KD patients suffer from obvious hyperoxidant stress, and improved in response to IVIG treatment in most patients. Blood BAP level might be a useful index for predicting responsiveness to IVIG the treatment. (Circ J 2011; 75: 2453-2459)
論文 | ランダム
- 肥満と糖尿病--インスリン抵抗性の評価と臨床的意義 (シンポジウム 肥満の臨床--第657回新潟医学会)
- 日本人2型糖尿病インスリン療法の開始にはBOTがよいのか? (特集 内科診療における論点) -- (内分泌・代謝)
- 症例報告 混合型インスリンアナログ製剤治療中に生じたインスリン抗体による血糖不安定性を来たした糖尿病の2症例--成因に関する考察を含めて
- 2型糖尿病の強化インスリン療法におけるNPHインスリンからインスリンデテミルへの切り替え効果--18ヶ月間の長期観察の検討
- 原発性副甲状腺機能亢進症による高カルシウムクリーゼに対しゾレドロネートが奏効した末期腎不全患者の1例